Free Trial

Dimerix (DXB) News Today

Dimerix logo
Petra Capital Reaffirms Their Buy Rating on Dimerix Limited (DXB)
Dimerix Corrects Director Interest Notice
Companies Like Dimerix (ASX:DXB) Can Afford To Invest In Growth
Dimerix’s Phase 3 Kidney Trial Progresses Successfully
Dimerix Gains $7.9 Million Boost for R&D Initiatives
Dimerix Collaborates with NEPTUNE for Trial Recruitment
Dimerix Announces Key Developments in Kidney Disease Trials
Dimerix Limited Issues Unquoted Equity Options for Employees
Get Dimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for DXB and its competitors with MarketBeat's FREE daily newsletter.

DXB Media Mentions By Week

DXB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DXB
News Sentiment

1.29

0.86

Average
Medical
News Sentiment

DXB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DXB Articles
This Week

3

1

DXB Articles
Average Week

Get Dimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for DXB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (ASX:DXB) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners